Stock Scorer

Healthcare Services Group Inc (HCSG)

Healthcare Services Group Inc reported revenue of 470.8M USD for the quarter ending 30 June 2026, up 2.7% from 458.5M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 470.8M +2.7%
Gross Profit Q2 '26 · ending 30 June 2026 74.8M +2428.5%
Net Income Q2 '26 · ending 30 June 2026 22.7M —
Cost of Revenue Q2 '26 · ending 30 June 2026 396M -13.1%
Operating Cash Flow Q2 '26 · ending 30 June 2026 21.9M -24.0%
Free Cash Flow Q2 '26 · ending 30 June 2026 20.2M -26.2%
Shares Outstanding Q2 '26 · ending 30 June 2026 69.9M -5.5%
EPS Q2 '26 · ending 30 June 2026 1.71 +1121.4%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.8B—59.1M139.2M
20242024-12-31 1.7B—39.5M24.5M
20232023-12-31 1.7B—38.4M38.1M
20222022-12-31 1.7B—34.2M-13.4M
20212021-12-31 1.6B—48.5M31.4M
20202020-12-31 1.8B—98.7M212.9M
20192019-12-31 1.8B—64.6M89.2M
20182018-12-31 2B—83.5M75.1M
20172017-12-31 1.9B—88.2M2.2M
20162016-12-31 1.6B—77.4M36M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30470.8M
Q1 '262026-03-31462.8M
Q4 '252025-12-31466.7M
Q3 '252025-09-30464.3M
Q2 '252025-06-30458.5M
Q1 '252025-03-31447.7M
Q4 '242024-12-31437.8M
Q3 '242024-09-30428.1M
Q2 '242024-06-30426.3M
Q1 '242024-03-31423.4M
Q4 '232023-12-31423.8M
Q3 '232023-09-30411.4M
Q2 '232023-06-30418.9M
Q1 '232023-03-31417.2M
Q4 '222022-12-31424M
Q3 '222022-09-30414.5M
Q2 '222022-06-30424.9M
Q1 '222022-03-31426.8M
Q4 '212021-12-31420.4M
Q3 '212021-09-30415.6M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q2 '262026-06-3074.8M
Q1 '262026-03-3175.8M
Q4 '252025-12-3172.1M
Q3 '252025-09-3096.4M
Q2 '252025-06-303M
Q1 '252025-03-3168M
Q4 '242024-12-3158.6M
Q3 '242024-09-3063.4M
Q2 '242024-06-3041.5M
Q1 '242024-03-3164.5M
Q4 '232023-12-3174.7M
Q3 '232023-09-3034.5M
Q2 '232023-06-3050.7M
Q1 '232023-03-3154.9M
Q4 '222022-12-3156.7M
Q3 '222022-09-3037.6M
Q2 '222022-06-3045.5M
Q1 '222022-03-3153.5M
Q4 '212021-12-3146.9M
Q3 '212021-09-3050.8M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-3022.7M
Q1 '262026-03-3126.1M
Q4 '252025-12-3131.2M
Q3 '252025-09-3043M
Q2 '252025-06-30-32.4M
Q1 '252025-03-3117.2M
Q4 '242024-12-3111.9M
Q3 '242024-09-3014M
Q2 '242024-06-30-1.8M
Q1 '242024-03-3115.3M
Q4 '232023-12-3123.5M
Q3 '232023-09-30-5M
Q2 '232023-06-308.3M
Q1 '232023-03-3111.7M
Q4 '222022-12-3115.8M
Q3 '222022-09-30322K
Q2 '222022-06-306.8M
Q1 '222022-03-3111.3M
Q4 '212021-12-314.8M
Q3 '212021-09-309.5M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30396M
Q1 '262026-03-31386.9M
Q4 '252025-12-31394.6M
Q3 '252025-09-30367.9M
Q2 '252025-06-30455.5M
Q1 '252025-03-31379.7M
Q4 '242024-12-31379.2M
Q3 '242024-09-30364.7M
Q2 '242024-06-30384.7M
Q1 '242024-03-31358.9M
Q4 '232023-12-31349.1M
Q3 '232023-09-30376.9M
Q2 '232023-06-30368.2M
Q1 '232023-03-31362.4M
Q4 '222022-12-31367.3M
Q3 '222022-09-30376.9M
Q2 '222022-06-30379.4M
Q1 '222022-03-31373.3M
Q4 '212021-12-31373.5M
Q3 '212021-09-30364.8M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3021.9M
Q1 '262026-03-3143.7M
Q4 '252025-12-3117.4M
Q3 '252025-09-3071.3M
Q2 '252025-06-3028.8M
Q1 '252025-03-3127.5M
Q4 '242024-12-3136.2M
Q3 '242024-09-304.3M
Q2 '242024-06-3016.3M
Q1 '242024-03-31-26M
Q4 '232023-12-3149.4M
Q3 '232023-09-302.9M
Q2 '232023-06-307.4M
Q1 '232023-03-31-16.3M
Q4 '222022-12-3122.9M
Q3 '222022-09-30-9.9M
Q2 '222022-06-309M
Q1 '222022-03-31-30.2M
Q4 '212021-12-3131.4M
Q3 '212021-09-30-23.1M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-3020.2M
Q1 '262026-03-3142.3M
Q4 '252025-12-3116M
Q3 '252025-09-3070M
Q2 '252025-06-3027.4M
Q1 '252025-03-3125.8M
Q4 '242024-12-3134.8M
Q3 '242024-09-302.9M
Q2 '242024-06-3015M
Q1 '242024-03-31-28.2M
Q4 '232023-12-3148M
Q3 '232023-09-301.1M
Q2 '232023-06-306.3M
Q1 '232023-03-31-17.3M
Q4 '222022-12-3121.8M
Q3 '222022-09-30-11.5M
Q2 '222022-06-307.8M
Q1 '222022-03-31-31.6M
Q4 '212021-12-3129.9M
Q3 '212021-09-30-25.2M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3069.9M
Q1 '262026-03-3171M
Q3 '252025-09-3073M
Q2 '252025-06-3073.2M
Q1 '252025-03-3174M
Q3 '242024-09-3073.9M
Q2 '242024-06-3073.9M
Q1 '242024-03-3174.1M
Q3 '232023-09-3074.4M
Q2 '232023-06-3074.6M
Q1 '232023-03-3174.5M
Q3 '222022-09-3074.3M
Q2 '222022-06-3074.4M
Q1 '222022-03-3174.3M
Q3 '212021-09-3075.1M
Q2 '212021-06-3075.2M
Q1 '212021-03-3175.2M
Q3 '202020-09-3074.8M
Q2 '202020-06-3074.8M
Q1 '202020-03-3174.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-301.71
Q1 '262026-03-310.95
Q4 '252025-12-310.81
Q3 '252025-09-300.54
Q2 '252025-06-300.14
Q1 '252025-03-310.56
Q4 '242024-12-310.54
Q3 '242024-09-300.70
Q2 '242024-06-300.44
Q1 '242024-03-310.57
Q4 '232023-12-310.52
Q3 '232023-09-300.41
Q2 '232023-06-300.48
Q1 '232023-03-310.46
Q4 '222022-12-310.45
Q3 '222022-09-300.31
Q2 '222022-06-300.44
Q1 '222022-03-310.48
Q4 '212021-12-310.66
Q3 '212021-09-300.96